Calidi Biotherapeutics, Inc. Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate
Calidi Biotherapeutics, Inc. (CLDI) had Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate of 24.00% as of 2024-09-30, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Debt
us-gaap:LongTermDebtPercentageBearingVariableInterestRate · last filed 2025-03-31
- 2024-09-30: Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate 24.00%.
| Period end | Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate |
|---|---|
| 2024-09-30 | 24.00% 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |